- Volume 26 Issue 2
DOI QR Code
Resveratrol Induces Cell Death through ROS-dependent MAPK Activation in A172 Human Glioma Cells
사람의 신경교모세포종 기원 세포에서 레스베라트롤에 의한 활성산소종 생성 증가와 MAPK 활성화를 통한 세포 사멸 효과
Jung, Jung Suk;Woo, Jae Suk
- Received : 2015.12.14
- Accepted : 2016.01.28
- Published : 2016.02.25
Glioblastoma multiforme is the most common and most aggressive type of primary brain tumor in humans. Despite intensive treatment, including surgery, radiation, and chemotherapy, most patients die of the disease. Although the anti-cancer activity of resveratrol has been demonstrated in various cancer cell types, its underlying mechanism in glioma cells is not fully elucidated. The present study was undertaken to investigate the effect of resveratrol on cell viability and to determine the molecular mechanism in A172 human glioma cells. Resveratrol caused the generation of reactive oxygen species (ROS), and resveratrol-induced cell death was prevented by antioxidants (N-acetylcysteine and catalase), suggesting that an oxidative mechanism is responsible for resveratrol-induced cell death. Resveratrol-induced phosphorylation of extracellular signal-regulated kinase (ERK), p38 kinase, and c-Jun N-terminal kinase (JNK), and resveratrol-induced cell death were prevented by inhibitors of these kinases. Resveratrol-induced activation of caspase-3 and cell death were prevented by the caspase inhibitors. ERK activation and caspase-3 activation induced by resveratrol was blocked by N-acetylcysteine. Taken together, these results suggest that resveratrol causes a caspase-dependent cell death via activation of ERK, p38, and JNK, mediated by ROS generation, in human glioma cells.
Cell viability;glioma cells;MAPK;resveratrol;reactive oxygen species
- Kuwajerwala, N., Cifuentes, E., Gautam, S., Menon, M., Barrack, E. R. and Reddy, G. P. 2002. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Cancer Res. 62, 2488-2492.
- Martindale, J. L. and Holbrook, N. J. 2002. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell Physiol. 192, 1-15. https://doi.org/10.1002/jcp.10119
- Ohgaki, H. and Kleihues, P. 2005. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 64, 479-489. https://doi.org/10.1093/jnen/64.6.479
- Ren, W., Qiao, Z., Wang, H., Zhu, L. and Zhang, L. 2003. Flavonoids: promising anticancer agents. Med. Res. Rev. 23, 519-534. https://doi.org/10.1002/med.10033
- Shankar, S., Singh, G. and Srivastava, R. K. 2007. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci. 12, 4839-4854. https://doi.org/10.2741/2432
- Siddiqui, I. A., Sanna, V., Ahmad, N., Sechi, M. and Mukhtar, H. 2015. Resveratrol nanoformulation for cancer prevention and therapy. Ann. NY Acad. Sci. 1348, 20-31. https://doi.org/10.1111/nyas.12811
- Yang, J. H., Hsia, T. C., Kuo, H. M., Chao, P. D., Chou, C. C., Wei, Y. H. and Chung, J. G. 2006. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug. Metab. Dispos. 34, 296-304.
- Zulueta, A., Caretti, A., Signorelli, P. and Ghidoni, R. 2015. Resveratrol: A potential challenger against gastric cancer. World J. Gastroenterol. 21, 10636-10643. https://doi.org/10.3748/wjg.v21.i37.10636
- Jiang, H., Zhang, L., Kuo, J., Kuo, K., Gautam, S. C., Groc, L., Rodriguez, A. I., Koubi, D., Hunter, T. J., Corcoran, G. B., Seidman, M. D. and Levine, R. A. 2005. Resveratrol-induced apoptotic death in human U251 glioma cells. Mol. Cancer Ther. 4, 554-561. https://doi.org/10.1158/1535-7163.MCT-04-0056
- Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D. and Weinstein, I. B. 2002. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8, 893-903.
- Kanadaswami, C., Lee, L. T., Lee, P. P., Hwang, J. J., Ke, F. C., Huang, Y. T. and Lee, M. T. 2005. The antitumor activities of flavonoids. In Vivo 19, 895-909.
- Kao, C. L., Huang, P. I., Tsai, P. H., Tsai, M. L., Lo, J. F., Lee, Y. Y., Chen, Y. J., Chen, Y. W. and Chiou, S. H. 2009. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int. J. Radiat. Oncol. Biol. Phys. 74, 219-228. https://doi.org/10.1016/j.ijrobp.2008.12.035
- Kim, E. J., Choi, C. H., Park, J. Y., Kang, S. K. and Kim, Y. K. 2008. Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem. Res. 33, 971-979. https://doi.org/10.1007/s11064-007-9416-8
- Kim, K. W., Choi, C. H., Kim, T. H., Kwon, C. H., Woo, J. S. and Kim, Y. K. 2009. Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo. Neurochem. Res. 34, 1479-1490. https://doi.org/10.1007/s11064-009-9935-6
- Kma, L. 2013. Synergistic effect of resveratrol and radiotherapy in control of cancers. Asian Pac. J. Cancer Prev. 14, 6197-6208. https://doi.org/10.7314/APJCP.2013.14.11.6197
- Kundu, J. K. and Surh, Y. J. 2008. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 269, 243-261. https://doi.org/10.1016/j.canlet.2008.03.057
- Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S. and Takada, Y. 2004. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24, 2783-2840.
- Bhardwaj, A., Sethi, G., Vadhan-Raj, S., Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S. and Aggarwal, B. B. 2007. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109, 2293-2302. https://doi.org/10.1182/blood-2006-02-003988
- Clement, M. V., Hirpara, J. L., Chawdhury, S. H. and Pervaiz, S. 1998. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996-1002.
- Cobb, M. H. 1999. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71, 479-500. https://doi.org/10.1016/S0079-6107(98)00056-X
- Cohen, G. M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16. https://doi.org/10.1042/bj3260001
- DeAngelis, L. M. 2001. Brain tumors. N. Engl. J. Med. 344, 114-123. https://doi.org/10.1056/NEJM200101113440207
- Fresco, P., Borges, F., Diniz, C. and Marques, M. P. 2006. New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 26, 747-766. https://doi.org/10.1002/med.20060
- Jeong, J. C., Kim, M. S., Kim, T. H. and Kim, Y. K. 2009. Kaempferol induces cell death through ERK and Akt-dependent down-regulation of XIAP and survivin in human glioma cells. Neurochem. Res. 34, 991-1001. https://doi.org/10.1007/s11064-008-9868-5